Alteration of serum thrombopoietin levels in patients with chronic hepatitis C under interferon therapy

Clinical Hemorheology and Microcirculation

Volumn 44, Issue 2, 2010, Pages 137-144

  Wenzel, Folker ^a   Gruber, Wolfgang ^a   Giers, Günther ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Blood platelet count; Chronic hepatitis C; Interferon therapy; Regulation of TPO concentration; Serum TPO concentration; Thrombopoietin

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; THROMBOPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HUMAN; MALE; THROMBOCYTE COUNT;

ADULT; AGED; ANTIVIRAL AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 77950266142     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1262     Document Type: Article

References (39)

1. A.M.D. Bisceglie, P.Martin, C. Kassianidies, M. Lisker-Melman, L. Murry, J.Waggoner, Z. Goodman et al., Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial, N. Engl. J. Med. 321 (1989), 1506-1510.
2. V.C. Broudy, N.L. Liu, D.F. Sabath, T. Papayannopoulos and K. Kaushansky, Human platelets display high-affinity receptor for thrombopoietin, Blood 89 (1997), 1896-1904.
3. G.L. Davis, L.A. Balart, E.R. Schiff, K. Lindsay, H.C. Bodenheimer Jr., R.P. Perillo, W. Carey et al., The International Hepatitis Therapy Group, Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial, N. Engl. J. Med. 321 (1989), 1501-1506.
4. M. Dettke, M. Hlousek, M. Kurz, G. Leitner, K. Rosskopf, G. Stiegler, P. Stohlawetz et al., Increase in endogenous thrombopoietin in healthy donors after automated platelet pheresis, Transfusion 38 (1998), 449-453.
5. D.L. Eaton and F.J. de Sauvage, Thrombopoietin: The primary regulator of megakaryocyto-poiesis and thrombopoiesis, Exp. Hematol. 25 (1997), 1-7.
6. R.V. Emmons, D.M. Reid, R.L. Cohen, N.S. Young, C.E. Dunbar and N.R. Shulman, Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction, Blood 87 (1996), 4068-4071.
7. C. Engel, M. Loeffler, H. Franke and S. Schmitz, Endogenous thrombopoietin serum levels during multicycle chemotherapy, Br. J. Haematol. 105 (1999), 832-838.
8. M.L. Evangelista, S. Amadori and R. Stasi, Biologic aspects of thrombopoietin and the development of novel thrombopoietic agents for clinical use, Curr. Drug Discov. Technol. 4 (2007), 162-173.
9. P.J. Fielder, P. Hass, M. Nagel, E. Stefanich, R. Widmer, G.L. Bennett, G.A. Keller et al., Human platelets as a model for the binding and degradation of thrombopoietin, Blood 89 (1997), 2782-2788.
10. R.G. Geissler, O.G. Ottmann, G. Kojouharoff, P. Reutzel, M. Eder, D. Hoelzer and A. Ganser, Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individuals, AIDS Res. Hum. Retroviruses 8 (1992), 521-525.
11. T. Gori, F. Jung and S. Forconi, Principles of ethical authorship for publication in Clinical Hemorheology and Microcirculation, Clin. Hemorheol. Microcirc. 43 (2009), 189-190.
12. F. Heits, D.M. Katschinski, U.Wilmsen, G.J.Wiedemann andW. Jelkmann, Serum thrombopoietin and interleukin-6 concentrations in tumour patients and response to chemotherapy-induced thrombocytopenia, Eur. J. Haematol. 59 (1997), 53-59.
13. L.E. Hellström, L.L. Kanter, J. Nichol and A. Ost, Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology, Scandinavian MDS Group, Sweden and Norway, Br. J. Haematol. 105 (1999), 966-973.
14. M. Hou, P.O. Andersson, D. Stockelberg, U.H. Melölqvist, B. Ridell and H. Wadenvik, Plasma thrombopoietin levels in thrombocytopenic states: implication for regulatory role of bone marrow megakaryocytes, Br. J. Haematol. 101 (1998), 420-424.
15. T. Ishikawa, T. Ichida, J. Matsuda, S. Sugitani, M. Sugiyama, T. Kato, H. Miyazaki et al., Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis, J. Gastroenterol. Hepatol. 13 (1998), 907-913.
16. W. Jelkmann, The role of the liver in the production of thrombopoietin compared with erythropoietin, Eur. J. Gastroenterol. Hepatol. 13 (2001), 791-801.
17. K. Kaushansky, Thrombopoietin: the primary regulator of platelet production, Blood 86 (1995), 419-431.
18. K. Kaushansky, Thrombopoietin, N. Eng. J. Med. 339 (1998), 746-754.
19. D.J. Kuter, New thrombopoietic growth factors, Blood 109 (2007), 4607-4616.
20. S. Lok, K. Kaushansky, R.D. Holly, J.L. Kuijper, C.E. Loften-Day, P.J. Oort, F.J. Grant et al., Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo, Nature 369 (1994), 565-568.
21. T.G. Martin 3rd, K.A. Somberg, J.G. Meng, R.L. Cohn, C.A. Heid, F.J. de Sauvage and M.A. Shuman, Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation, Ann. Intern. Med. 127 (1997), 285-288.
22. Y.G. Meng, T.G. Martin, M.L. Peterson, M.A. Shuman, R.L. Cohen and W.L. Wong, Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation, Br. J. Haematol. 95 (1996), 535-541.
23. I. Michelmann, D. Böckmann, W. Nürnberger, S. Eckhof-Donovan, S. Burdach and U. Göbel, Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man, Ann. Hematol. 74 (1997), 174-184.
24. Y. Nagata, Y. Shozaki, H. Nagahisa, T. Nagasawa, T. Abe and K. Todokoro, Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis, Thromb. Haemost. 77 (1997), 808-812.
25. T. Okanoue, S. Sakamoto, Y. Itoh, M. Minami, K. Yasui, M. Sakamoto, K. Nishioji et al., Side effects of high-dose interferon therapy for chronic hepatitis C, J. Hepatol. 25 (1996), 283-291.
26. C.E. Omoti, C.E. Omuemu and A.N. Olu-Eddo, The rheological profile of chronic liver disease patients in Nigeria, Clin. Hemorheol. Microcirc. 42 (2009), 279-284.
27. M. Peck-Radoslavljevic, M. Wichlas, J. Pidlich, P. Sims, G. Meng, J. Zacherl, S. Garg et al., Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C, Hepatology 28 (1998), 1424-1429.
28. S. Porubcin, I. Schréter, P. Kristian and A. Pellová, Haematologic adverse effects of treatment of chronic viral hepatitis B and C, Klin. Mikrobiol. Infekc. Lek. 14 (2008), 74-78.
29. M. Sata, Y. Yano, Y. Yoshiyama, T. Ide, R. Kumashiro, H. Suzuki and K. Tanikawa, Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B, J. Gastroenterol. 32 (1997), 206-210.
30. F.J. de Sauvage, P.E. Hass, S.D. Spencer, B.E. Mollony, A.L. Gurney, S.A. Spencer, W.C. Darbonne et al., Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand, Nature 369 (1994), 533-538.
31. G. Shiota, M. Okubo, H. Kawasaki and T. Tahara, Interferon increases serum thrombopoietin in patients with chronic hepatitis C, Br. J. Haematol. 97 (1997), 340-342.
32. R. Stoffel, A. Wiestner and R.C. Skoda, Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets, Blood 87 (1996), 567-573.
33. R. Sungaran, B. Markovic and B.H. Chong, Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization, Blood 89 (1997), 101-107.
34. T. Tahara, K. Usuki, H. Sato, H. Ohashi, H. Morita, H. Tsumura, A. Matsumoto et al., A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders, Br. J. Haematol. 93 (1996), 783-786.
35. E.A. Trowbridge, J.F. Martin, D.N. Slater, Y.T. Kishk, C.W. Warren, P.J. Harley and B. Woodcock, The origin of platelet count and volume, Clin. Phys. Physiol. Meas. 5 (1984), 145-170.
36. W. Vogel, Treatment of acute hepatitis C virus infection, J. Hepatol. 31(Suppl.) (1999), 189-192.
37. F.Wenzel, I. Kafka, T. Gettmann, R. Görlich and G. Giers, Are serum thrombopoietin levels influenced by megakaryocytic thrombopoiesis of the bone marrow?, Clin. Chem. Lab. Med. 44 (2006), A169.
38. E.M. Wolber, R. Gauschow, M. Burdelski and W. Jelkmann, Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood, Hepatology 29 (1999), 1739-1742.
39. A. Yamane, T. Nakamura, H. Suzuki, M. Ito, Y. Ohnishi, Y. Ikeda and Y. Miyakawa, Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes, Blood 112 (2008), 542-550.